Trial intelligence / Profile preview

NRD101 vs sodium hyaluronate in knee osteoarthritis

CTR20170250Phase 3Completed

Sponsor
Chugai Pharmaceutical Co., Ltd.
Start
Mar 2017
Countries
1
01

Overview

A Phase 3 trial of hyaluronic acid in knee osteoarthritis (OA), sponsored by Chugai Pharmaceutical Co., Ltd.. Started Mar 2017; status: completed.

02

Drugs

hyaluronic acid
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on CTR20170250.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20170250.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call